We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Bone Marrow May Reverse Sickle Cell Damage

By HospiMedica staff writers
Posted on 17 Apr 2001
A study suggests that cranial artery damage in patients with sickle cell disease may be reversed through bone marrow transplant. More...
The study was published in the February issue of Annals of Neurology.

Many sickle cell patients suffer from vasculopathy, or damaged blood vessels. The damage may be caused by the high rate of blood flow that is typical of patients with this type of anemia. Brain damage and cognitive impairment may be common symptoms. Reversing the progression of vasculopathy through bone marrow transplant may prevent brain damage. Studies are underway to determine if bone marrow transplantation can improve the cognitive ability of patients. The bone marrow of sickle cell patients does not have to be completely obliterated prior to transplant, as is the case for patients with leukemia or other types of cancer.

"As we get older, our arteries clog up with plaque—the older you get, the more clogged they become,” said Grant Steen, Ph.D., author of the study, who conducted the research at St. Jude Children's Research Hospital (Memphis, TN, USA; www.stjude.org). "But in kids with sickle cell disease, you can see vasculopathy that might be typical of a 65-year-old hypertensive person, only the child is eight or ten, or sometimes even two years old.”




Related Links:
St. Jude Children's Hospital

Gold Member
SARS‑CoV‑2/Flu A/Flu B/RSV Sample-To-Answer Test
SARS‑CoV‑2/Flu A/Flu B/RSV Cartridge (CE-IVD)
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Absorbable Monofilament Mesh
Phasix Mesh
Bipolar Coagulation Generator
Aesculap
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.